Literature DB >> 8756182

The energetics of ligand binding at catecholamine receptors.

P G Strange1.   

Abstract

One of the key events in the actions of agonists and antagonists is their binding to receptors. Understanding this event is of interest in terms of understanding receptor function but it also has immense practical relevance for the design of drugs. If the ligand-binding process could be understood in detail, including the nature of the interactions made between ligand and receptor, then this could help in the design of more-selective drugs. The interaction of a ligand with its receptor is clearly of importance in determining the specificity of ligand action but ligand-receptor interaction also initiates the processes of signalling that are exhibited in the efficacy of ligand action. Here Philip Strange considers these events for catecholamine receptors, concentrating mostly on dopamine receptors; where necessary the discussion is widened to include other receptor systems.

Mesh:

Substances:

Year:  1996        PMID: 8756182     DOI: 10.1016/0165-6147(96)10025-0

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  3 in total

1.  Agonist binding to G-protein coupled receptors.

Authors:  P G Strange
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Analysis of molecular determinants of affinity and relative efficacy of a series of R- and S-2-(dipropylamino)tetralins at the 5-HT1A serotonin receptor.

Authors:  J Tracy Alder; Uli Hacksell; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

3.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.